Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Amortizatization of Intangibles (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Amortizatization of Intangibles for 6 consecutive years, with $8000.0 as the latest value for Q4 2018.

  • Quarterly Amortizatization of Intangibles changed 0.0% to $8000.0 in Q4 2018 from the year-ago period, while the trailing twelve-month figure was $31000.0 through Dec 2018, changed 0.0% year-over-year, with the annual reading at $31000.0 for FY2018, 0.0% changed from the prior year.
  • Amortizatization of Intangibles hit $8000.0 in Q4 2018 for Armata Pharmaceuticals, roughly flat from $8000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $15000.0 in Q3 2014 to a low of $7000.0 in Q2 2015.
  • Historically, Amortizatization of Intangibles has averaged $8157.9 across 5 years, with a median of $8000.0 in 2014.
  • Biggest YoY gain for Amortizatization of Intangibles was 100.57% in 2014; the steepest drop was 99.7% in 2014.
  • Year by year, Amortizatization of Intangibles stood at $8000.0 in 2014, then changed by 0.0% to $8000.0 in 2015, then changed by 0.0% to $8000.0 in 2016, then changed by 0.0% to $8000.0 in 2017, then changed by 0.0% to $8000.0 in 2018.
  • Business Quant data shows Amortizatization of Intangibles for ARMP at $8000.0 in Q4 2018, $8000.0 in Q3 2018, and $7000.0 in Q2 2018.